newsfilter
← Latest News
GlobeNewswire·

Mentari Therapeutics to Present at Upcoming Investor Conferences

  • Mentari Therapeutics (Nasdaq: MTRI) announced management participation in three upcoming investor conferences in November 2026.
  • The Guggenheim 3rd Annual Healthcare Conference is scheduled for Monday, November 9 at 4:00 p.m. ET.
  • The Stifel 2026 Healthcare Conference is scheduled for Thursday, November 12 at 10:00 a.m. ET.
  • The 2026 Jefferies Global Healthcare Conference in London is scheduled for Tuesday, November 17 at 11:00 a.m. GMT.
  • Live webcasts & archived recordings for these events will be available on Mentari's website for 90 days post-conference.
  • The company is developing next-generation migraine prevention therapies, including lead programs MT-001 (anti-PACAB monoclonal antibody) & MT-002 (anti-PACAB/anti-CGRP bispecific antibody).
  • Mentari Therapeutics is a clinical-stage biotechnology firm based in Waltham, MA, with programs discovered by Paragon.
Company
Mentari Therapeutics, Inc.
Keywords
Nasdaq:MTRI, Mentari Therapeutics, Inc.